A PK Study of IkT-148009 in Older and Elderly Healthy Subjects
Clinical trial NCT06644326 · COMPLETED
Trial details
- NCT number
- NCT06644326
- Sponsor
- ABLi Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-21
- Primary completion
- 2024-08-17
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.